HomeBUSINESS
BUSINESS

Takeda/TiGenix Cell Therapy for Crohn’s Disease Complication Gets European Panel Nod
(Dec.19.2017)

Takeda Pharmaceutical and Belgium biotech TiGenix said on December 15 that their stem cell therapy Cx601 (darvadstrocel) has earned the green light of a key European panel for treating complex perianal fistulas in Crohn’s disease ...
(LOG IN FOR FULL STORY)